Breaking News
October 16, 2018 - Poor Outcomes for Hispanic Infants With Congenital Heart Dz
October 16, 2018 - Global study finds youngest in class more likely to be diagnosed with ADHD
October 16, 2018 - Researchers sequence two selfish genes in the fungus Neurospora intermedia
October 16, 2018 - Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis
October 16, 2018 - Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration
October 16, 2018 - Researchers create open access database on healthy immunity
October 16, 2018 - Rice University chemist wins big award to study small surfaces
October 16, 2018 - Study finds 43% drop in stroke rate
October 16, 2018 - Researchers identify basic relationships of cell cycle and cellular senescence in the placenta
October 16, 2018 - Obesity Doubles Odds for Colon Cancer in Younger Women
October 16, 2018 - Adults with ADHD not constrained in creativity
October 16, 2018 - Raising visibility for people and students with chronic illness and disability
October 16, 2018 - Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis
October 16, 2018 - Only 59% of young adults undergoing surgery are fluid responsive
October 16, 2018 - Research points to potential new treatment for hearing loss
October 16, 2018 - MDI Biological Laboratory receives $1.2 million SEPA grant to promote data literacy
October 16, 2018 - Vast majority of dementia cases may arise from spontaneous genetic errors
October 16, 2018 - New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases
October 16, 2018 - Study identifies molecular switch that controls fate of milk-producing breast cells
October 16, 2018 - Research shows diet has little influence on precursor to gout
October 16, 2018 - “Without Dr. Shumway doing his miracle work, three generations would not be here”: A Stanford heart transplant patient’s story
October 16, 2018 - Non-invasive brain stimulation sheds light on neurobiology underlying implicit bias
October 16, 2018 - Researchers demonstrate integrated technique to control production of cell therapeutics
October 16, 2018 - Breast tomosynthesis detects 34% more tumors than traditional mammography
October 16, 2018 - Rhode Island Hospital, Brown receive $800,000 grant to keep up fight against opioid epidemic
October 16, 2018 - UVA partners with health systems in AVIA network’s Medicaid Transformation Project
October 16, 2018 - Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
October 16, 2018 - Study reveals early warning signs of heart problems in patients with newly diagnosed lupus
October 16, 2018 - Connecting the dots of Alzheimer’s disease
October 16, 2018 - New publication offers evidence-based content for global breast imaging medical community
October 16, 2018 - ‘EinsteinVision’ that improves hand-eye coordination of surgeons introduced at Harefield Hospital
October 16, 2018 - WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine
October 16, 2018 - Ketamine can be considered as alternative to opioids for short-term pain control in ED
October 16, 2018 - Endurance exercise training beneficially alters gut microbiota composition
October 15, 2018 - FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
October 15, 2018 - Birthing Options for Full-Term Pregnancy
October 15, 2018 - Stressed, toxic, zombie cells seen for first time in Alzheimer’s
October 15, 2018 - Concussion researchers study head motion in high school football hits | News Center
October 15, 2018 - Neuropsychiatric symptoms related to earliest stages of Alzheimer’s brain pathology
October 15, 2018 - Neck collar device may help protect the brain of female high school soccer players
October 15, 2018 - Research reveals how the inner ear processes speech
October 15, 2018 - Many parents still skeptical about safety and effectiveness of flu shot, survey finds
October 15, 2018 - Payer Policies May Discourage Non-Pharma Tx for Low Back Pain
October 15, 2018 - Exercise may delay cognitive decline in people with rare Alzheimer’s disease
October 15, 2018 - Researchers modify CRISPR to reorganize genome | News Center
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Study highlights need for increased support for alcohol-related liver disease patients
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Schiller Easy Pulse Saves Lives
October 15, 2018 - The latest ECG device from Schiller
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
October 15, 2018 - Engineering teratoma-derived fibroblasts to enhance osteogenesis
October 15, 2018 - Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism
October 15, 2018 - JCU study firms up association between diet and depression
October 15, 2018 - Researchers to study the use of CRISPR on human liver on-a-chip platform
October 15, 2018 - Sub-concussive impacts not associated with decline in neurocognitive function
October 15, 2018 - Researchers find potential treatment to halt premature labor and birth
October 15, 2018 - As U.S. suicides rates rise, Hispanics show relative immunity
October 15, 2018 - FDA Issues a Complete Response Letter to Acacia Pharma for Barhemsys
October 15, 2018 - Photoactive bacteria bait may help in fight against MRSA infections
October 15, 2018 - Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children
October 15, 2018 - First-of-its-kind study to test a personalized vaccine in cancer patient
October 15, 2018 - Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia
Endovascular Graft Methods: Letter to Well being Care Suppliers – Kind III Endoleaks Related to Use

Endovascular Graft Methods: Letter to Well being Care Suppliers – Kind III Endoleaks Related to Use

image_pdfDownload PDFimage_print

September 28, 2017

Target audience: Possibility Supervisor, Surgical treatment, Cardiology, Radiology

[Posted 09/28/2017]

ISSUE: The FDA is comparing fresh knowledge referring to Kind IIIa and IIIb endoleaks with the usage of endovascular graft methods indicated for a process referred to as endovascular aneurysm restore (EVAR). EVAR treats stomach aortic aneurysms (AAA) and aorto-iliac-aneurysms.

Contemporary knowledge from a number of resources, together with FDA’s Scientific Software Reporting (MDR) machine and Annual Medical Updates to Physicians through the producers, suggests an build up within the incidence of Kind III endoleaks. This build up is in comparison to previous scientific replace stories in sufferers with quite a lot of system fashions and implant period lengths, together with some sufferers who had in the past solid maintenance. 

FDA is bringing this attainable complication on your consideration to remind and inspire you to file Kind IIIa and IIIb endoleak occasions to the producer and the FDA. This may occasionally come with reporting person occasions in addition to charges you’ll have skilled for your apply.

The FDA continues to paintings with all producers of endovascular graft methods to raised perceive this factor, together with the superiority of Kind III endoleaks, contributing components, and the hazards and advantages of secondary interventions to handle those endoleaks. The FDA will stay the general public knowledgeable as important new knowledge turns into to be had.

BACKGROUND: EVAR is meant to exclude the AAA sac from the arterial circulate and save you AAA rupture, which is a life-threatening match. Within the presence of a Kind III endoleak, AAA isn’t excluded from waft and systemic arterial pressurization of the aneurysm sac, leading to an higher possibility of rupture.

The FDA considers a Kind III endoleak a device-related match which calls for remedy with further interventions akin to re-lining, insertion of extra endograft parts, or open surgical restore. The secondary interventions to handle endoleaks elevate added dangers for impacted sufferers. Predictors of Kind III endoleak would possibly come with remedy with early technology graft fabrics, the presence of calcified plaque, and insufficient overlap between parts.

RECOMMENDATIONS: The FDA recommends that well being care suppliers:

  • Proceed lifelong surveillance of sufferers who’ve been handled with endovascular grafts.
  • Believe Kind III endoleaks within the differential analysis of sufferers presenting with signs of attainable aneurysm growth or rupture.
  • Seek advice from your sufferers all to be had remedy choices to handle Kind III endoleaks, together with the hazards and advantages of every, sooner than deciding the most productive remedy manner.
  • Record any of the next to MedWatch, the FDA Protection Knowledge and Hostile Match Reporting Program On-line Voluntary Reporting Shape:
    • early or past due device-related opposed occasions–together with Kind IIIa and IIIb endoleaks–related to the usage of endovascular graft methods in EVAR;
    • device-related opposed occasions that happen on account of a secondary intervention to regard Kind III endoleaks.
  • Software producers and person amenities should agree to the appropriate Scientific Software Reporting (MDR) laws. Well being care body of workers hired through amenities which are topic to FDA’s person facility reporting necessities will have to practice the reporting procedures established through their amenities. Suggested reporting of inauspicious occasions can lend a hand the FDA establish and higher perceive the hazards related to scientific gadgets.

Healthcare pros and sufferers are inspired to file opposed occasions or unintended effects associated with the usage of those merchandise to the FDA’s MedWatch Protection Knowledge and Hostile Match Reporting Program:

  • Whole and put up the file On-line: www.fda.gov/MedWatch/file
  • Obtain shape or name 1-800-332-1088 to request a reporting shape, then whole and go back to the deal with at the pre-addressed shape, or put up through fax to 1-800-FDA-0178

[09/28/2017 – Letter to Health Care Providers – FDA]

Tagged with:

About author

Related Articles